These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 3806581
1. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors. Daly JW, Padgett WL, Shamim MT. J Med Chem; 1986 Jul; 29(7):1305-8. PubMed ID: 3806581 [Abstract] [Full Text] [Related]
2. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions. Shamim MT, Ukena D, Padgett WL, Daly JW. J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296 [Abstract] [Full Text] [Related]
3. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Choi OH, Shamim MT, Padgett WL, Daly JW. Life Sci; 1988 Jun; 43(5):387-98. PubMed ID: 2456442 [Abstract] [Full Text] [Related]
13. 7-Deaza-9-phenyladenines. A new class of adenosine receptor antagonists. Daly JW, Padgett WL, Eger K. Biochem Pharmacol; 1988 Oct 01; 37(19):3749-53. PubMed ID: 3178888 [Abstract] [Full Text] [Related]
14. 8-Azaxanthine derivatives as antagonists of adenosine receptors. Franchetti P, Messini L, Cappellacci L, Grifantini M, Lucacchini A, Martini C, Senatore G. J Med Chem; 1994 Sep 02; 37(18):2970-5. PubMed ID: 8071944 [Abstract] [Full Text] [Related]
15. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes. Ukena D, Schudt C, Sybrecht GW. Biochem Pharmacol; 1993 Feb 24; 45(4):847-51. PubMed ID: 7680859 [Abstract] [Full Text] [Related]
16. Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptors. Katsushima T, Nieves L, Wells JN. J Med Chem; 1990 Jul 24; 33(7):1906-10. PubMed ID: 1694546 [Abstract] [Full Text] [Related]
17. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists. Jacobson KA, Gallo-Rodriguez C, Melman N, Fischer B, Maillard M, van Bergen A, van Galen PJ, Karton Y. J Med Chem; 1993 May 14; 36(10):1333-42. PubMed ID: 8496902 [Abstract] [Full Text] [Related]
18. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. Sarges R, Howard HR, Browne RG, Lebel LA, Seymour PA, Koe BK. J Med Chem; 1990 Aug 14; 33(8):2240-54. PubMed ID: 2374150 [Abstract] [Full Text] [Related]
19. N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor. Thompson RD, Secunda S, Daly JW, Olsson RA. J Med Chem; 1991 Sep 14; 34(9):2877-82. PubMed ID: 1895305 [Abstract] [Full Text] [Related]
20. Chronic effects of xanthines on levels of central receptors in mice. Shi D, Daly JW. Cell Mol Neurobiol; 1999 Dec 14; 19(6):719-32. PubMed ID: 10456233 [Abstract] [Full Text] [Related] Page: [Next] [New Search]